Assessment and modulation of forsythiaside absorption with MDCKII cells and validation with in situ intestinal experiment

Investigation on the absorption of phillyrin and forsythiaside in rat digestive tract

(2011) Yun-xia Li et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting

(2009) Arik Dahan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

An LC-MS/MS method for determination of forsythiaside in rat plasma and application to a pharmacokinetic study

(2009) Geng-Nan Wang et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs

(2009) Pär Matsson et al.   PHARMACEUTICAL RESEARCH

Prediction of oral drug absorption in humans – from cultured cell lines and experimental animals

(2008) K-C Cheng et al.   Expert Opinion on Drug Metabolism & Toxicology

In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors

(2008) Roula Konsoula et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol

(2008) K. van de Wetering et al.   MOLECULAR PHARMACOLOGY

Determination of forsythiaside in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies

(2007) Yun-Xia Li et al.   BIOMEDICAL CHROMATOGRAPHY